CREATE: Art for Children With Cancer

Part of paid clinical trials in Portland, Oregon.

Sponsor
OHSU Knight Cancer Institute
Study ID
NCT06342453
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
8 Years - 13 Years
Healthy Volunteers
Not accepted

Interventions

  • Art Therapy — PROCEDURE
    Participate in CrA
  • Discussion — PROCEDURE
    Participate in art focus group, art-making
  • Media Intervention — OTHER
    Watch videos
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of complementary health interventions which have been associated with improved quality of life and reduced symptom burden among children with cancer. CrA is an ideal intervention for children with cancer due to the long hours spent in the hospital setting for treatments, the creativity and developmental focus of children, and their potential ability to communicate more easily through art than words. Researchers want to develop and test a CrA intervention to help improve symptoms and the quality of life of children with cancer.

Key Dates

Start date
Jun 4, 2024
Status verified
Mar 2026
Primary completion
Jul 1, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
72 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Phase I (focus group)
    Patients participate in focus groups to develop CrA intervention on study.
  • Experimental: Phase II arm I (CrA)
    Patients participate in CrA interventions comprising drawing, painting, and making sculptures with a trained artist for 30 minutes once a week for 4 sessions over 12 weeks.
  • Active Comparator: Phase II arm II (watch videos)
    Patients passively watch videos for 30 minutes once a week for 4 sessions over 12 weeks.

Primary Outcome Measure

Number of participants that complete all interventions and data collection time points [ Time Frame: Up to day 90 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OHSU Knight Cancer InstitutePortlandOregon97239
Jennifer L. Raybin
[email protected]
503-418-5150
Jennifer L. Raybin (PRINCIPAL_INVESTIGATOR)

Find similar trials in Portland, OR

By research site
OHSU Knight Cancer Institute· Portland, OR

Related Studies